Azenta, Inc. (NASDAQ:AZTA – Get Rating) saw a significant drop in short interest during the month of December. As of December 30th, there was short interest totalling 7,480,000 shares, a drop of 5.1% from the December 15th total of 7,880,000 shares. Currently, 11.1% of the company's shares are short sold. Based on an average daily volume of 874,400 shares, the days-to-cover ratio is currently 8.6 days.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. Glassman Wealth Services purchased a new position in shares of Azenta in the second quarter valued at $25,000. Quadrant Capital Group LLC purchased a new stake in shares of Azenta in the 2nd quarter worth approximately $26,000. Castle Wealth Management LLC bought a new position in Azenta in the 2nd quarter valued at approximately $34,000. Assetmark Inc. bought a new position in Azenta in the 2nd quarter worth $39,000. Finally, SeaCrest Wealth Management LLC purchased a new position in shares of Azenta during the second quarter valued at about $48,000. 96.42% of the stock is owned by institutional investors and hedge funds.
Get Azenta alerts:Azenta Stock Down 0.4 %
AZTA stock opened at $56.89 on Wednesday. The company has a 50-day simple moving average of $59.04 and a 200 day simple moving average of $55.27. The company has a market capitalization of $3.93 billion, a P/E ratio of 2.01 and a beta of 1.61. Azenta has a fifty-two week low of $37.61 and a fifty-two week high of $93.39.
Azenta (NASDAQ:AZTA – Get Rating) last released its quarterly earnings data on Monday, November 14th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.10. Azenta had a return on equity of 1.31% and a net margin of 383.23%. The firm had revenue of $137.57 million during the quarter, compared to analyst estimates of $132.01 million. Equities analysts anticipate that Azenta will post 0.33 EPS for the current year.Analyst Ratings Changes
A number of equities research analysts have recently issued reports on AZTA shares. KeyCorp cut their price objective on shares of Azenta from $90.00 to $70.00 and set an "overweight" rating for the company in a research report on Monday, October 24th. Stephens raised their target price on shares of Azenta from $60.00 to $65.00 in a research note on Thursday, November 17th. TheStreet raised shares of Azenta from a "d+" rating to a "c-" rating in a report on Tuesday, December 13th. Finally, Needham & Company LLC boosted their price target on shares of Azenta from $74.00 to $78.00 and gave the stock a "buy" rating in a research report on Tuesday, November 15th. Four research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of "Buy" and an average price target of $72.60.
About Azenta
(Get Rating)
Azenta, Inc is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples.
Recommended Stories
- Get a free copy of the StockNews.com research report on Azenta (AZTA)
- 3 Retail Stocks Ringing the Register in 2023
- When Will Crane Holdings Take Flight?
- Is It Time To Get Aggressive With Defense Stocks?
- EVgo Stock is Charged Up to Ride the EV Adoption Wave
- Qualcomm Gets a Boost from Analysts, but is it Time to Buy?
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.